At week 52 in PIONEER 10, the use of additional anti-diabetic use and rescue medication use was 6% to 18% and 2% to 17%, respectively, for patients in semaglutide treatment groups and 12% and 9%, respectively in the dulaglutide treatment group
At Klinic, our skilled providers specialize in semaglutide weight loss, ensuring you receive personalized care tailored to your needs
On a 0.3mL syringe, the lines are spaced further apart, giving you better precision for small doses but a maximum capacity of only 30 units
Direct NAD+ IV Tolerability A small 2026 commercial-infusion study reported short-term tolerability data and variable exploratory metabolic outcomes, with more research needed beyond 30 days
Anthropometric and biochemical parameters were assessed at baseline and week 12
If prescribed Toujeo, ask whether a GLP-1 agonist was considered and why it was not selected